Vivo Bio Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)
Vivo Bio Tech Ltd · Outcome · 12 Nov 2026, 12:46 am
Vivo Bio Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 1,719 (+31.1% YoY | +20.4% QoQ) ■ EBITDA: 608 (+12.4% YoY | +20.4% QoQ) ■ EBITDA Margin (%): 35.4 (-590 bps YoY | +0 bps QoQ) ■ PAT: 110 (+26.9% YoY | +487.5% QoQ) ■ EPS (INR): 0.50 (+11.1% YoY | +525.0% QoQ)
Original exchange filing (PDF)
More announcements from Vivo Bio Tech Ltd
- Please find the enclosed · 13 Nov 2026
- Please find enclosed · 12 Nov 2026
- Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Vivo Bio Tech Ltd has informed .... · 11 Nov 2026
- Please find enclosed · 13 Oct 2026
- Please find Enclosed · 10 Oct 2026
- Please find enclosed scrutinizer''s report for 39th AGM · 01 Oct 2026
- Please find enclosed · 01 Oct 2026
- Please find enclosed 39th AGM proceedings · 01 Oct 2026
